Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

The lotion with specific plant extracts effectively increased hair growth and improved hair cycle in subjects after 3 months.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Particulate matter causes inflammation in hair cells, potentially harming hair growth.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

JAK inhibitors show promise in treating moderate to severe alopecia areata.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Blocking a specific immune cell signal can trigger hair growth.

Blocking JAK-STAT5 signaling in mice leads to hair growth.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Topical JAK inhibitors may help treat hair loss.

Oral JAK inhibitors help regrow hair in alopecia patients.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Three compounds from Dadap leaves may help treat hair loss.